Japan Lifts Decades-Old Bans On Somatropin In Diabetes, IFNβ In Pregnancy
Pressure From Doctors And Companies
Executive Summary
Japan cautiously lifts decades-old bans on somatropin’s use in diabetic patients and interferon beta 1a/1b in pregnant patients, judging benefits can outweigh risks and following requests from doctors and pharma firms to consider patients.